Skip to main content
. 2015 Dec 8;2015(12):CD008093. doi: 10.1002/14651858.CD008093.pub2

Sousonis 2014.

Study characteristics
Methods Single centre randomised controlled trial
Setting: Patients with heart failure and with more than 7000 PVCs/24 h
Country: Greece
Participants N = 20 (10 amiodarone + standard medical therapy, 10 standard medical therapy)
Sex: 80‐100% male
Age: mean 59‐62 years
Inclusion: consecutive HF patients (LVEF ≤ 40%, mean LVEF: 31 ± 7%) with more than 7000 PVCs/24 h (primary prevention)
Interventions Group 1: amiodarone (200 mg/d) + standard medical therapy
Group 2: standard medical therapy alone
Duration: 6 months
Outcomes All‐cause mortality, cardiac mortality, SCD
Notes Presented as a poster in the 2014 Heart Failure Congress, we have unpublished data given to us by the author. At 6 months follow‐up, only 8 patients´s status was known in the control group.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote from the author: "a total of 20 consecutive patients were randomised in a 1:1 treatment allocation"
Allocation concealment (selection bias) Unclear risk The trial was randomised, but allocation concealment wasn't described
Blinding of participants and personnel (performance bias)
All outcomes High risk Quote from the author: "Only the 24 h Holter overreading physician was blinded during the study."
Blinding of outcome assessment (detection bias)
All outcomes High risk From the author: The outcome assessor was not blind to the group which the patients were assigned to.
Incomplete outcome data (attrition bias)
Objective outcomes (death) High risk There were 2 patients lost in the control group at the 6‐month follow‐up
Incomplete outcome data (attrition bias)
Subjective outcomes (quality of life) Unclear risk No description regarding any aspect of any subjective outcome
Selective reporting (reporting bias) Low risk The study protocol was not available, but it is clear that the published report includes all expected outcomes
Other bias High risk Due to the small number of participants, it is difficult to adequately consider other confounding factors